Carnegie Capital Asset Management, LLC Abb Vie Inc. Transaction History
Carnegie Capital Asset Management, LLC
- $3.34 Billion
- Q3 2024
A detailed history of Carnegie Capital Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 38,431 shares of ABBV stock, worth $6.92 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
38,431
Previous 37,179
3.37%
Holding current value
$6.92 Million
Previous $6.38 Million
19.02%
% of portfolio
0.23%
Previous 0.2%
Shares
31 transactions
Others Institutions Holding ABBV
# of Institutions
3,853Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.9 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.2 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.38 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.97 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $318B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...